APOE and Alzheimer disease: In terms of disease penetrance, research consistently shows that males and females with APOE4 homozygosity have a similar risk and predictability of the age at AD diagnosis (Fortea et al., 2024; Jansen et al., 2022; Therriault et al., 2021; Zou et al., 2023).